sotorasib,docetaxel
amgen,sanofi,aventis
['sotorasib', 'nsclc', 'codebreak 200', 'sclc', 'docetaxel']
codebreak 200, randomized trial of sotorasib vs docetaxel in pts w/ kras g12c mutant nsclc pre treated with chemo &amp; io #esmo22: pfs 5.6 vs 4.5 mo (hr 0.66) orr 28.1 % vs. 13.2% dcr 82.5% vs 60.3% improved safety profile &amp; pros as expected with sotorasib 
MD, PhD - Asst Prof, Thoracic Oncology & Precision Medicine Unit Coordinator (CEMIC) ????. Implementing precision medicine programs in LATAM with PxMedica